Literature DB >> 26561739

Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles.

Helerin Margus1, Piret Arukuusk2, Ülo Langel2,3, Margus Pooga1.   

Abstract

Nucleic acids are highly promising candidates for the treatment of various genetic diseases. However, due to the large size and negative charge, nucleic acids are not efficiently taken up by cells, and thus, their clinical potential remains limited so far. Therefore, various delivery vehicles have been designed to assist the cellular uptake of nucleic acids. Among these, cell-penetrating peptides (CPPs) have gained increasing popularity as efficient and nontoxic delivery vectors. CPPs can be coupled to nucleic acids either by covalent or noncovalent association. Noncovalent coupling, which is based on the formation of nanoparticle-like nanocomplexes (NP), has received much attention in recent years, and the number of studies employing the strategy is explosively increasing due to the high therapeutic potential. However, the properties of CPP/nucleic acid NPs have not been characterized in sufficient detail yet. We performed a comprehensive analysis of the size and morphology of nucleic acid nanoparticles with novel transfection peptides, PepFects (PFs) and NickFects (NFs), using negative staining transmission electron microscopy (TEM). In addition, we examined whether the attachment of fluorescence or (nano)gold label to nucleic acid affects the nanocomplex formation or its morphology. We demonstrated that transportan-10-based new generation CPPs from PF and NF families condense nucleic acids to NPs of homogeneous size and shape. The size and shape of assembled nanoparticles depend on the type of the complexed nucleic acid and the sequence of the used peptide, whereas the label on the nucleic acid does not influence the gross characteristics of formed NPs.

Entities:  

Keywords:  cell-penetrating peptide; negative staining; noncovalent strategy; nucleic acid delivery; transmission electron microscopy

Mesh:

Substances:

Year:  2015        PMID: 26561739     DOI: 10.1021/acs.molpharmaceut.5b00598

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  Membrane Molecular Interactions and Induced Structures of CPPs.

Authors:  Fatemeh Madani; Astrid Gräslund
Journal:  Methods Mol Biol       Date:  2022

2.  Formulation of Stable and Homogeneous Cell-Penetrating Peptide NF55 Nanoparticles for Efficient Gene Delivery In Vivo.

Authors:  Krista Freimann; Piret Arukuusk; Kaido Kurrikoff; Ly Pärnaste; Raivo Raid; Andres Piirsoo; Margus Pooga; Ülo Langel
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-20       Impact factor: 8.886

3.  The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides.

Authors:  Ly Pärnaste; Piret Arukuusk; Kent Langel; Tanel Tenson; Ülo Langel
Journal:  Mol Ther Nucleic Acids       Date:  2017-02-10

Review 4.  Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics.

Authors:  Graham McClorey; Subhashis Banerjee
Journal:  Biomedicines       Date:  2018-05-05

5.  Targeted gene silencing in human embryonic stem cells using cell-penetrating peptide PepFect 14.

Authors:  Egle-Helene Ervin; Martin Pook; Indrek Teino; Valmar Kasuk; Annika Trei; Margus Pooga; Toivo Maimets
Journal:  Stem Cell Res Ther       Date:  2019-01-24       Impact factor: 6.832

6.  Biological activity of gold nanoparticles combined with the NFL-TBS.40-63 peptide, or with other cell penetrating peptides, on rat glioblastoma cells.

Authors:  A Griveau; C Arib; J Spadavecchia; J Eyer
Journal:  Int J Pharm X       Date:  2022-09-16

7.  Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin for Intracellular Delivery of DNA in Human A549 Cells.

Authors:  Betty R Liu; Yue-Wern Huang; Robert S Aronstam; Han-Jung Lee
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

8.  Role of autophagy in cell-penetrating peptide transfection model.

Authors:  Moataz Dowaidar; Maxime Gestin; Carmine Pasquale Cerrato; Mohammed Hakim Jafferali; Helerin Margus; Paula Ann Kivistik; Kariem Ezzat; Einar Hallberg; Margus Pooga; Mattias Hällbrink; Ülo Langel
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.